Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
Conditions: Non Hodgkin Lymphoma; Multiple Myeloma; Chronic Lymphocytic Leukemia; Diffuse Large B Cell Lymphoma; Mantle Cell Lymphoma; Follicular Lymphoma Interventions: Genetic: JCAR017; Genetic: JCARH125 Sponsor: Juno Therapeutics, Inc. Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials